Earnings Summary

Chromadex Corp’s revenue jumped 0.95% since last year same period to $21.2Mn in the Q4 2023. On a quarterly growth basis, Chromadex Corp has generated 8.73% jump in its revenue since last 3-months.

Chromadex Corp’s net profit fell -83.06% since last year same period to $0.11Mn in the Q4 2023. On a quarterly growth basis, Chromadex Corp has generated 111.89% jump in its net profits since last 3-months.

Chromadex Corp’s net profit margin fell -83.22% since last year same period to 0.54% in the Q4 2023. On a quarterly growth basis, Chromadex Corp has generated 110.93% jump in its net profit margins since last 3-months.

Chromadex Corp’s earning per share (EPS) estimates for the current quarter stand at -0.02 - a 33.33% jump from last quarter’s estimates.

Chromadex Corp’s earning per share (EPS) estimates for the current year stand at -0.02.

Chromadex Corp’s earning per share (EPS) jumped 107.5% since last year same period to 0 in the Q4 2023. This indicates that the Chromadex Corp has generated 107.5% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Chromadex Corp’s return on assets (ROA) stands at -0.06.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Chromadex Corp’s return on equity (ROE) stands at -0.17.